Stephen J. Haggarty

Active 1998–2025

109
Papers
31,236
Citations
71
h-index
105
i10-index

Citations

Citations per year for Stephen J. Haggarty1980: 1 citations1991: 1 citations1994: 1 citations1996: 1 citations1998: 2 citations1999: 5 citations2000: 32 citations2001: 28 citations2002: 29 citations2003: 58 citations2004: 72 citations2005: 96 citations2006: 98 citations2007: 87 citations2008: 165 citations2009: 208 citations2010: 339 citations2011: 429 citations2012: 407 citations2013: 475 citations2014: 488 citations2015: 475 citations2016: 466 citations2017: 385 citations2018: 436 citations2019: 1,171 citations2020: 1,355 citations2021: 1,234 citations2022: 1,076 citations2023: 802 citations2024: 1,072 citations2025: 534 citations2026: 28 citations1981–1990: no citations, so these years are not shown1992–1993: no citations, so these years are not shown1995: no citations, so this year is not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,883 citing papers, 31.2% of this breakdownChina: 1,861 citing papers, 11.9% of this breakdownUnited Kingdom: 1,019 citing papers, 6.5% of this breakdownGermany: 819 citing papers, 5.2% of this breakdownCanada: 571 citing papers, 3.6% of this breakdownItaly: 493 citing papers, 3.2% of this breakdownFrance: 398 citing papers, 2.5% of this breakdownIndia: 389 citing papers, 2.5% of this breakdownJapan: 373 citing papers, 2.4% of this breakdownNetherlands: 349 citing papers, 2.2% of this breakdownSpain: 334 citing papers, 2.1% of this breakdownAustralia: 306 citing papers, 2% of this breakdown
0%31.2%Other 24.7%

Fields

  • Biochemistry, Genetics and Molecular Biology53.3%
  • Medicine19.5%
  • Neuroscience10.5%
  • Computer Science10.3%
  • Chemistry1.2%
  • Immunology and Microbiology1.2%
  • Other4%

Topics

  • Computational Drug Discovery Methods5.3%
  • Histone Deacetylase Inhibitors Research4.2%
  • Bioinformatics and Genomic Networks4.1%
  • Epigenetics and DNA Methylation3.3%
  • Genetics and Neurodevelopmental Disorders2.9%
  • Protein Degradation and Inhibitors2.4%
  • Other77.8%

Coauthors

All papers

Open in search
  1. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anita Vrcic, Corey Flynn, Jacqueline Rosains, David Y. Takeda, Roger Hu, Desiree Davison, Justin Lamb, Kristin Ardlie, Larson Hogstrom, Peyton Greenside, Nathanael S. Gray, Paul A. Clemons, Serena J. Silver, Xiaoyun Wu, Wen‐Ning Zhao, Willis Read-Button, Xiaohua Wu, Stephen J. Haggarty, Lucienne Ronco, Jesse S. Boehm, Stuart L. Schreiber, John G. Doench, Joshua A. Bittker, David E. Root, Bang Wong, Todd R. Golub - Cell 2017 cited by 3,788

  2. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Science 2006 cited by 5,510

  3. HDAC2 negatively regulates memory formation and synaptic plasticity

    Authors: , , , , , , , , , , , , , - Nature 2009 cited by 1,653

  4. An epigenetic blockade of cognitive functions in the neurodegenerating brain

    Authors: , , , , , , , , , , , , , , , - Nature 2012 cited by 859

  5. Combining NGN2 Programming with Developmental Patterning Generates Human Excitatory Neurons with NMDAR-Mediated Synaptic Transmission

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Reports 2018 cited by 276

  6. HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2020 cited by 209

  7. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models

    Authors: , , , , , , , , , , , , , - eLife 2019 cited by 274

  8. Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease

    Authors: , , , , , , - Neuropsychopharmacology 2009 cited by 725

  9. ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2021 cited by 169

  10. Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen

    Authors: , , , , , - Science 1999 cited by 1,739

  11. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 1,058

  12. Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons

    Authors: , , , , , , , , , - Nature Communications 2020 cited by 158

  13. Chemical phylogenetics of histone deacetylases

    Authors: , , , , , , - Nature Chemical Biology 2010 cited by 728

  14. A psychiatric disease-related circular RNA controls synaptic gene expression and cognition

    Authors: , , , , , , , , , , , , , , , , , - Molecular Psychiatry 2020 cited by 167

  15. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling

    Authors: , , , , , , , , , , , , , , , , - Molecular Psychiatry 2017 cited by 311

  16. Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing

    Authors: , , , , , , , , , , , - Nature Communications 2023 cited by 52

  17. A polygenic burden of rare disruptive mutations in schizophrenia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven A. McCarroll, Pamela Sklar - Nature 2014 cited by 1,461

  18. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 353

  19. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce L. Miller, Li Gan, Alison Goate, Sally Temple, Carolina Alquézar, Kathryn R. Bowles, David Butler, John F. Crary, Li Gan, Alison Goate, Stephen J. Haggarty, Israel Hernández, Valerie Hennes, Cindy Huang, Justin K. Ichida, Martin Kampmann, Aimee W. Kao, Celeste M. Karch, Anna Karydas, Kenneth S. Kosik, Rita Martinez, Khadijah Onanuga, M. Catarina Silva, Sally Temple, Chao Wang, M. Catarina Silva, Sally Temple, Sally Temple, Chao Wang - Stem Cell Reports 2019 cited by 126

  20. A Cdk5-derived peptide inhibits Cdk5/p25 activity and improves neurodegenerative phenotypes

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 59

  21. An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons

    Authors: , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2017 cited by 145

  22. Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation

    Authors: , , , , , , , , , , - Science 2010 cited by 801

  23. Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling

    Authors: , , , , , , , , , , , , , , - Cell 2009 cited by 783

  24. Discovery and Optimization of Tau Targeted Protein Degraders Enabled by Patient Induced Pluripotent Stem Cells-Derived Neuronal Models of Tauopathy

    Authors: , , , , , , , , , - Frontiers in Cellular Neuroscience 2022 cited by 49